Residential substance abuse and mental health facilities provide medical services, room, board, supervision and counseling services to patients suffering from mental illness or substance abuse.
Read Report at: https://www.thebusinessresearchcompany.com/report/residential-substance-abuse-and-mental-health-facilities-global-market-report-2018
The reasons for the market being valued at $147 billion in 2017 is economic growth, socio-economic factors, increased incidence of drug and alcohol abuse and integration driving the growth.
In the report, the global residential substance and mental health facilities market is divided into two segments. Mental health & intellectual disability facilities occupy the major share, accounting for more than four-fifth of the market and substance abuse centers occupy one-fifth of the market share.
Request a sample of the report at:
The USA was the largest country in the residential substance abuse and mental health facilities market in 2017, accounting for close to two-fifth of the market share. France and Germany followed the USA as the next largest countries in the market.
The residential substance abuse and mental health facilities market is fragmented with a number of large and small organizations. The top five competitors in the market made up 25% of the total market share in 2017. National Health Service was the largest competitor of the market, followed by Universal Health Services, Acadia Healthcare Company, Inc., Kindred Healthcare Inc. and Genesis Healthcare. The UK’s National Health Service is the publicly funded health care system created under the UK’s National Health Service Act. The organization was launched in 1948. It has more than 1.5 million employees.
About The Business Research Company.
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]